Robert F. Wilson, M.D.
Professor of Medicine (Interventional Cardiology)
Fred C. and Katherine B. Andersen Foundation Chair in Adult Clinical Cardiology
Executive Medical Director,
University of Minnesota Physicians Cardiovascular Service Line
Director, Interventional-Cardiology Fellowship Program
- Interventional Cardiology
- Heart -- University of Minnesota Physicians Heart at Fairview
- UMPhysicians Heart at University of Minnesota Medical Center, Fairview
University of Iowa
University of Texas, San Antonio (Internal Medicine)
University of Iowa (Cardiovascular Disease)
Dr. Wilson has dedicated his professional life to developing new methods for diagnosing and treating heart disease, and to training new physicians. He presently directs the University of Minnesota interventional-cardiology fellowship program and University of Minnesota Physicians clinical cardiovascular services.
A graduate of the University of Iowa College of Medicine, Dr. Wilson completed his residency at the University of Texas Health Science Center at San Antonio and his cardiology fellowship at the University of Iowa. He joined the University of Minnesota faculty in 1986, when he and Dr. Carl White established a training program that has graduated over 50 interventional cardiologists. From 1988-2004, Dr. Wilson served as the director of the University of Minnesota Medical Center-Fairview’s cardiac catheterization laboratory.
Dr. Wilson’s investigative career initially focused on coronary physiology in humans. He developed the first catheter for the selective measure of coronary bloodflow in humans, and described the effects of atherosclerosis and transplantation on coronary bloodflow. He also first identified reinnervation of the transplanted human heart and its effects on cardiac function. Later, Dr. Wilson developed semi-computerized injection systems for coronary angiography that now used annually for millions of patients worldwide.
Dr. Wilson’s present research focus is the development of a prosthetic heart valve that can be inserted through a small catheter, eliminating the need for open-heart valve surgery. This device is now in human clinical trials.
Dr. Wilson holds numerous patents for cardiovascular treatment devices. The National Institute of Health, the American Heart Association, and private individuals have supported his work.
Yannopoulos D, Zviman M, Castro V, Kolandaivelu A, Ranjan R, Wilson RF, Halperin HR. Intra-cardiopulmonary resuscitation hypothermia with and without volume loading in an ischemic model of cardiac arrest. Circulation 2009;120:1426-1435
Bank AJ, Berry JM, Wilson RF, Lester BR. Acceptance criteria for reprocessed AcuNav catheters: Comparison between functionality testing and clinical image assessment. Ultrasound Med Biol 2009;35:507-514
Henry TD, Satran D, Wilson RF. Phase I cardiovascular cell-therapy clinical trials: Are we running with scissors? Am Heart J 2008;156:808-09
Navaravong L, Wilson RF. The case of the broken-hearted woman: A middle-aged female with acute coronary symptoms. Minn Med 2008;91:42-43
Wilson RF, Raveendran G. What's good for the gander is now good for the goose. JACC 2008;51:2321-2322
Wilson RF, Henry TD. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: Double-edged swords. JACC 2005;46:1649-1650
Muehling OM, Panse P, Jerosch-Herold M, Wilson BV, Wilson RF, Wilke NM, Miller LW. Cardiac magnetic-resonance perfusion imaging identifies transplant arteriopathy by a reduced endomyocardial resting perfusion. J Heart Lung Transplant 2005;24:1122-1123